Design Therapeutics, Inc. (DSGN) — DEF 14A Filings
All DEF 14A filings from Design Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Design Therapeutics Proxy Statement Filed
— Apr 24, 2025 Risk: low
Design Therapeutics, Inc. filed its definitive proxy statement on April 24, 2025, for its annual meeting of stockholders on June 10, 2025. The filing outlines t -
Design Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 25, 2024 Risk: low
Design Therapeutics, Inc. (DSGN) filed a Proxy Statement (DEF 14A) with the SEC on April 25, 2024. Annual Meeting of Stockholders to be held on June 13, 2024, a
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX